DN-9693 FREE BASE

O=C1CN2CC3=C(NC2=N1)C=CC(=C3)N4CCCCC4

InChIKey=MNVCNERGJZWWAO-UHFFFAOYSA-N

InChI=1S/C15H18N4O/c20-14-10-19-9-11-8-12(18-6-2-1-3-7-18)4-5-13(11)16-15(19)17-14/h4-5,8H,1-3,6-7,9-10H2,(H,16,17,20)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells.	2006-01	16432171

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:38:09 GMT 2025` Edited by `admin` on `Mon Mar 31 22:38:09 GMT 2025`
Record UNII	01Z3256K33
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

DN-9693 FREE BASE

Common Name

English

IMIDAZO(2,1-B)QUINAZOLIN-2(3H)-ONE, 1,5-DIHYDRO-7-(1-PIPERIDINYL)-

Preferred Name

English

Code System Code Type Description

EPA CompTox

DTXSID10914669

Created by admin on Mon Mar 31 22:38:09 GMT 2025 , Edited by admin on Mon Mar 31 22:38:09 GMT 2025

PRIMARY

FDA UNII

01Z3256K33

Created by admin on Mon Mar 31 22:38:09 GMT 2025 , Edited by admin on Mon Mar 31 22:38:09 GMT 2025

PRIMARY

CAS

96086-67-8

Created by admin on Mon Mar 31 22:38:09 GMT 2025 , Edited by admin on Mon Mar 31 22:38:09 GMT 2025

PRIMARY

PUBCHEM

135410273

Created by admin on Mon Mar 31 22:38:09 GMT 2025 , Edited by admin on Mon Mar 31 22:38:09 GMT 2025

PRIMARY

Related Record Type Details


					01Z3256K33

ACTIVE MOIETY